EUS-guided Gastrojejunostomy Versus Laparoscopic Gastrojejunostomy: An International Collaborative Study
Manuel Perez-Miranda,Amy Tyberg,Daniel Poletto,Ernesto Toscano,Monica Gaidhane,Amit P. Desai,Nikhil A. Kumta,Lea Fayad,Jose Nieto,Marc Barthet,Raj Shah,Brian C. Brauer,Reem Z. Sharaiha,Michel Kahaleh,Poletto, Daniel,Nieto, Jose,Gaidhane, Monica,Kahaleh, Michel,Sharaiha, Reem Z.,Tyberg, Amy,Toscano, Ernesto,Desai, Amit P.,Fayad, Lea,Shah, Raj,Barthet, Marc,Perez-Miranda, Manuel,Brauer, Brian C.,Kumta, Nikhil A.
DOI: https://doi.org/10.1097/MCG.0000000000000887
2019-10-03
Journal of Clinical Gastroenterology
Abstract:Introduction:Endoscopic ultrasound–guided gastrojejunostomy (EUS-GJ) with placement of a lumen-apposing metal stent is a minimally invasive and efficacious procedure for gastric outlet obstruction (GOO) patients not amenable to surgery. Laparoscopic gastrojejunostomy (Lap-GJ) has traditionally been the standard of care. No direct comparison between EUS-GJ and Lap-GJ has been described. Our aim was to compare the clinical outcomes, success rate, and adverse events (AE) of EUS-GJ with Lap-GJ.
Methods:Patients with GOO from 4 academic centers in 3 countries were included. Technical success was defined as successful creation of a gastrojejunostomy. Clinical success was defined as the ability to tolerate a diet postprocedure.
Results:Data were collected on 54 patients. A total of 25 patients underwent EUS-GJ (male n=11, mean age 63.9 y) and 29 patients underwent Lap-GJ (male n=22, mean age 75.8 y). Technical success was achieved in 29 (100%) Lap-GJ group patients and 23 (88%) in the EUS-GJ group (P=0.11). AEs occurred in 41% (n=12) of patients in the Lap-GJ group and 12% (n=3) in the EUS-GJ group (P=0.0386). According to the Clavien-Dindo Classification, the Lap-GJ group AEs were grade I (n=4), grade II (n=5), grade III (n=2), and grade V (n=1); the EUS-GJ AEs were grade II (n=2) and grade V (n=1).
Conclusions:Although the EUS-GJ group contained more complex patients, efficacy was similar between the groups. AEs were significantly lower in the EUS-GJ group. EUS-GJ is a safe and efficacious, minimally invasive option for patients with GOO.
gastroenterology & hepatology